Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cellsBrian G. Till, Oliver W. Press, Andrew Raubitschek et al.|Blood|2008Cited by 719
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial resultsBrian G. Till, Oliver W. Press, Michael C. Jensen et al.|Blood|2012Cited by 530
HA-1–targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantationElizabeth F. Krakow, Marie Bleakley, Michelle Brault et al.|Blood|2024Cited by 29
Association of hepatitis B virus DNA levels with overall survival for advanced hepatitis B virus-related hepatocellular carcinoma under immune checkpoint inhibitor therapyMengchao An, Zibing Wang, Wenkang Wang et al.|Cancer Immunology Immunotherapy|2022Cited by 19